- Home
- PHI vs BCPC Comparison
PHI vs BCPC Comparison
Compare PHI & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHI
- BCPC
- Stock Information
- Founded
- PHI 1928
- BCPC 1967
- Country
- PHI Philippines
- BCPC United States
- Employees
- PHI N/A
- BCPC N/A
- Industry
- PHI Telecommunications Equipment
- BCPC Major Chemicals
- Sector
- PHI Telecommunications
- BCPC Industrials
- Exchange
- PHI Nasdaq
- BCPC Nasdaq
- Market Cap
- PHI 4.8B
- BCPC 5.3B
- IPO Year
- PHI 1953
- BCPC N/A
- Fundamental
- Price
- PHI $21.70
- BCPC $159.77
- Analyst Decision
- PHI
- BCPC Strong Buy
- Analyst Count
- PHI 0
- BCPC 1
- Target Price
- PHI N/A
- BCPC $180.00
- AVG Volume (30 Days)
- PHI 61.5K
- BCPC 132.1K
- Earning Date
- PHI 08-12-2025
- BCPC 07-25-2025
- Dividend Yield
- PHI 7.81%
- BCPC 0.54%
- EPS Growth
- PHI 14.93
- BCPC 17.80
- EPS
- PHI 2.54
- BCPC 4.17
- Revenue
- PHI $3,804,539,911.00
- BCPC $964,544,000.00
- Revenue This Year
- PHI $3.85
- BCPC $8.63
- Revenue Next Year
- PHI $2.33
- BCPC $6.85
- P/E Ratio
- PHI $8.37
- BCPC $38.32
- Revenue Growth
- PHI 2.38
- BCPC 3.76
- 52 Week Low
- PHI $20.29
- BCPC $145.70
- 52 Week High
- PHI $29.05
- BCPC $186.03
- Technical
- Relative Strength Index (RSI)
- PHI 39.92
- BCPC 37.46
- Support Level
- PHI $21.68
- BCPC $158.47
- Resistance Level
- PHI $22.09
- BCPC $168.41
- Average True Range (ATR)
- PHI 0.37
- BCPC 2.52
- MACD
- PHI -0.07
- BCPC -1.04
- Stochastic Oscillator
- PHI 27.10
- BCPC 13.08
About PHI PLDT Inc. Sponsored ADR
PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.
About BCPC Balchem Corporation
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.